Srini Tenjarla – Biography
Last update: March 16, 2026Executive profile
Srini was Vice President, Pharmaceutical Sciences at Takeda Pharmaceuticals International, and Vice President, Head of Small Molecules & Analytical Development at Shire Pharmaceuticals.
Srini Tenjarla is currentlySenior Vice President of Chemistry, Manufacturing, Controls, Product Development and Formulation at Serina Therapeutics - View - Serina Therapeutics org chart
Create your alert
to follow the career of Srini Tenjarla.
Education
Srini Tenjarla has a PhD from University of Houston.
They have also studied at University of Houston :
Find more alumni from University of Houston
More about Srini Tenjarla
Do you need to know more about Srini Tenjarla? More results.
Participate
Social media
- Srini Tenjarla on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Srini Tenjarla
The colleagues of Srini Tenjarla
Company Colleagues
- At Serina Therapeutics, Srini Tenjarla has 13 colleagues including Steve Ledger (CEO & Director), Karen Wilson (Director)…
Industry Colleagues
- In the Biotechnology industry, Srini Tenjarla has 35,761 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Srini Tenjarla.
Get in Touch
Here are a few tips for establishing great contacts.
